Main Actors of the Sales Recommendations
- Pernod Ricard: Barclays maintains its “Underweight” rating despite a slight increase in the price target (90→94 €), indicating structural weaknesses.
- BASF: JPMorgan keeps the “Underweight” rating, likely due to margin pressure and weak demand in key markets.
- Evonik: Jefferies confirms the “Underperform” rating, justified by high energy costs and stagnant demand in specialty chemicals.
- RATIONAL: Baader Bank sticks to the “Reduce” recommendation, possibly due to saturated sales markets in the gastro-equipment sector.
Backgrounds and Market Trends
The recommendations reflect broader concerns:
- Interest Rate Environment – Higher refinancing costs burden indebted corporations.
- Global Consumption Decline – Evident for Pernod Ricard through decreasing spirits demand in key markets like China.
- Energy Transformation – Chemical companies like BASF struggle with CO₂ regulations and production relocations.
Action Options for Investors
Experts recommend defensive strategies:
- ✅ Sector Rotation into utility or healthcare stocks with stable cash flow structures.
- ✅ Use Stop Losses to limit losses on sharply declining stocks (e.g., trailing stop-loss at 8–10% below purchase price).
The current clustering of “Sell” ratings indicates a phase of heightened volatility – retail investors should review portfolios for overweightings in critical sectors.